Anil Vachani

10.7k total citations · 2 hit papers
193 papers, 6.0k citations indexed

About

Anil Vachani is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Anil Vachani has authored 193 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 124 papers in Pulmonary and Respiratory Medicine, 63 papers in Oncology and 29 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Anil Vachani's work include Lung Cancer Diagnosis and Treatment (87 papers), Lung Cancer Treatments and Mutations (55 papers) and Global Cancer Incidence and Screening (29 papers). Anil Vachani is often cited by papers focused on Lung Cancer Diagnosis and Treatment (87 papers), Lung Cancer Treatments and Mutations (55 papers) and Global Cancer Incidence and Screening (29 papers). Anil Vachani collaborates with scholars based in United States, United Kingdom and Canada. Anil Vachani's co-authors include Steven Μ. Albelda, Sunil Singhal, Gerard A. Silvestri, Leslie A. Litzky, Michael K. Gould, Corey J. Langer, Larry R. Kaiser, Danielle Antin‐Ozerkis, Avrum Spira and Charu Aggarwal and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Anil Vachani

183 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer

2014 495 citations Anil Vachani, Leslie A. Litzky et al. profile →
Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer

2017 387 citations Anil Vachani et al. profile →

Peers

Countries citing papers authored by Anil Vachani

Since Specialization

Citations

This map shows the geographic impact of Anil Vachani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anil Vachani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anil Vachani more than expected).

Fields of papers citing papers by Anil Vachani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anil Vachani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anil Vachani. The network helps show where Anil Vachani may publish in the future.

Co-authorship network of co-authors of Anil Vachani

This figure shows the co-authorship network connecting the top 25 collaborators of Anil Vachani. A scholar is included among the top collaborators of Anil Vachani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anil Vachani. Anil Vachani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Monitoring the Harms of Lung Cancer Screening: Why the Nonmalignant Resection Rate Is Our Best Bet 2025 ·Journal of the American College of Radiology ·(unknown), Anil Vachani, Roger Y. Kim	0
2	Less Versus More Intensive Surveillance of Pulmonary Nodules Detected Incidentally or by Screening: A Survey of Radiologist Beliefs About Guidelines Implemented in the Watch the Spot Trial 2025 ·Journal of the American College of Radiology ·Michael K. Gould, (unknown), Lihong Qi, Evan de Bie, Denise R. Aberle, Debra S. Dyer, Sara E. Golden, Celia P. Kaplan, Richard A. Mularski, (unknown), (unknown), Anil Vachani, Renda Soylemez Wiener, Karen Kelly, Rebecca Smith‐Bindman, Diana L. Miglioretti	0
3	Rates of Downstream Procedures and Complications Associated With Lung Cancer Screening in Routine Clinical Practice 2024 ·Annals of Internal Medicine ·Katharine A. Rendle, (unknown), Anil Vachani, Andrea N. Burnett‐Hartman, V. Paul Doria‐Rose, (unknown), Christine Neslund‐Dudas, Caryn Oshiro, Roger Y. Kim, Jennifer Elston Lafata, Stacey Honda, Debra P. Ritzwoller, (unknown), Nandita Mitra, Robert T. Greenlee	22
4	Clinical utility of an artificial intelligence radiomics-based tool for risk stratification of pulmonary nodules 2024 ·JNCI Cancer Spectrum ·Roger Y. Kim, (unknown), (unknown), (unknown), Andrew J. Vickers, Katharine A. Rendle, Nandita Mitra, L. Pickup, David M. DiBardino, Anil Vachani	1
5	A Framework for Integrating Telehealth Equitably across the cancer care continuum 2024 ·JNCI Monographs ·Katharine A. Rendle, Andy S.L. Tan, Bonnie Spring, Erin M. Bange, Allison Lipitz‐Snyderman, Michael J. Morris, Danil V. Makarov, (unknown), Sofia F. Garcia, Brian Hitsman, (unknown), Siobhan M. Phillips, Scott E. Sherman, Peter D. Stetson, Anil Vachani, (unknown), Leah L. Zullig, Justin E. Bekelman	6
6	Quantifying the Value of Reduced Health Disparities: Low-Dose Computed Tomography Lung Cancer Screening of High-Risk Individuals Within the United States 2024 ·Value in Health ·Jason Shafrin, Jae‐Hong Kim, (unknown), (unknown), (unknown), (unknown), Iftekhar Kalsekar, Anil Vachani	3
7	Innovations in Early Lung Cancer Detection: Tracing the Evolution and Advancements in Screening 2024 ·Journal of Clinical Medicine ·(unknown), Peter B. Bach, (unknown), Caitlin A. Schonewolf, (unknown), Anil Vachani, Lisa Carter‐Harris, Ali H. Zaidi	6
8	Smoking status and the association between patient-level factors and survival among lung cancer patients 2023 ·JNCI Journal of the National Cancer Institute ·Nikki M. Carroll, Andrea N. Burnett‐Hartman, Katharine A. Rendle, Christine Neslund‐Dudas, Robert T. Greenlee, Stacey Honda, Anil Vachani, Debra P. Ritzwoller	2
9	Percentage Up to Date With Chest Computed Tomography Among Those Eligible for Lung Cancer Screening 2023 ·American Journal of Preventive Medicine ·Andrea N. Burnett‐Hartman, Nikki M. Carroll, Jennifer M. Croswell, Robert T. Greenlee, Stacey Honda, Christine Neslund‐Dudas, Roger Y. Kim, Katharine A. Rendle, Anil Vachani, Debra P. Ritzwoller	3
10	Application of team science best practices to the project management of a large, multi-site lung cancer screening research consortium 2023 ·Journal of Clinical and Translational Science ·(unknown), (unknown), Betsy Rolland, Courtney R. Kraus, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Nikki M. Carroll, (unknown), Andrew Sterrett, Katharine A. Rendle, (unknown), Anil Vachani, Debra P. Ritzwoller, Andrea N. Burnett‐Hartman	3
11	Racial Disparities in Adherence to Annual Lung Cancer Screening and Recommended Follow-Up Care: A Multicenter Cohort Study 2022 ·Annals of the American Thoracic Society ·Roger Y. Kim, Katharine A. Rendle, Nandita Mitra, (unknown), Christine Neslund‐Dudas, Robert T. Greenlee, Andrea N. Burnett‐Hartman, Stacey Honda, Michael Simoff, Marilyn M. Schapira, Jennifer M. Croswell, Rafael Meza, Debra P. Ritzwoller, Anil Vachani	39
12	Machine Learning and Real-World Data to Predict Lung Cancer Risk in Routine Care 2022 ·Cancer Epidemiology Biomarkers & Prevention ·Urmila Chandran, Jenna Reps, Robert Yang, Anil Vachani, Fabien Maldonado, Iftekhar Kalsekar	22
13	Artificial Intelligence Tool for Assessment of Indeterminate Pulmonary Nodules Detected with CT 2022 ·Radiology ·Roger Y. Kim, Jason Oke, L. Pickup, Reginald F. Munden, (unknown), Christina Bellinger, Avi J. Cohen, Michael Simoff, Pierre P. Massion, (unknown), Fergus Gleeson, Anil Vachani	42
14	A Veteran-Centric Web-Based Decision Aid for Lung Cancer Screening: Usability Analysis 2021 ·JMIR Formative Research ·Marilyn M. Schapira, Sumedha Chhatre, (unknown), (unknown), (unknown), Keri L. Rodriguez, Liana Fraenkel, Jeffrey D. Kravetz, Jeff Whittle, Lori A. Bastian, Anil Vachani, Scott Akers, (unknown), (unknown), Onur Asan	7
15	Timely follow‐up of positive cancer screening results: A systematic review and recommendations from the PROSPR Consortium 2018 ·CA A Cancer Journal for Clinicians ·Chyke A. Doubeni, Nicole B. Gabler, Cosette M. Wheeler, Anne Marie McCarthy, Philip E. Castle, Ethan A. Halm, Mitchell D. Schnall, Celette Sugg Skinner, Anna N.A. Tosteson, Donald L. Weaver, Anil Vachani, Shivan J. Mehta, Katharine A. Rendle, Stacey A. Fedewa, Douglas A. Corley, Katrina Armstrong	65
16	Whole blood FPR1 mRNA expression predicts both non‐small cell and small cell lung cancer 2018 ·International Journal of Cancer ·Scott Morris, Anil Vachani, Harvey I. Pass, William N. Rom, (unknown), Glen J. Weiss, D. Kyle Hogarth, George C. Runger, Donald Richards, Troy Shelton, David Mallery	14
17	Stakeholder Research Priorities for Smoking Cessation Interventions within Lung Cancer Screening Programs. An Official American Thoracic Society Research Statement 2017 ·American Journal of Respiratory and Critical Care Medicine ·Hasmeena Kathuria, Frank C. Detterbeck, Joelle T. Fathi, (unknown), Michael K. Gould, Denise Jolicoeur, Stephanie R. Land, Greta M. Massetti, Peter J. Mazzone, Gerard A. Silvestri, Christopher G. Slatore, Robert A. Smith, Anil Vachani, Steven B. Zeliadt, Renda Soylemez Wiener	25
18	Resection of Non–Small Cell Lung Cancers Reverses Tumor-Induced Gene Expression Changes in the Peripheral Immune System 2011 ·Clinical Cancer Research ·Andrew V. Kossenkov, Anil Vachani, Celia Chang, Calen Nichols, (unknown), Wen-Hwai Horng, William N. Rom, Steven Μ. Albelda, Michael K. Showe, Louise C. Showe	42
19	Gene Expression Profiles in Peripheral Blood Mononuclear Cells Can Distinguish Patients with Non–Small Cell Lung Cancer from Patients with Nonmalignant Lung Disease 2009 ·Cancer Research ·Michael K. Showe, Anil Vachani, Andrew V. Kossenkov, Malik Yousef, Calen Nichols, Elena V. Nikonova, Celia Chang, John C. Kucharczuk, (unknown), Elliot Wakeam, (unknown), David J. Speicher, William N. Rom, Steven Μ. Albelda, Louise C. Showe	125
20	A 10-Gene Classifier for Distinguishing Head and Neck Squamous Cell Carcinoma and Lung Squamous Cell Carcinoma 2007 ·Clinical Cancer Research ·Anil Vachani, Michael Nebozhyn, Sunil Singhal, (unknown), Elliot Wakeam, Ruth J. Muschel, Charles A. Powell, Patrick M. Gaffney, Bhuvanesh Singh, Marcia S. Brose, Leslie A. Litzky, John C. Kucharczuk, Larry R. Kaiser, J. S. Marron, Michael K. Showe, Steven Μ. Albelda, Louise C. Showe	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact